JPRN-UMIN000016152招募中未知
Multi-Center Study of Aflibercept Therapy for Neovascular Age-Related Macular Degeneration Using Trreat and Extend Strategy - Treat & Extend Stratedy with Aflibercept for AMD
Tokyo Women's Medical University0 个研究点目标入组 200 人开始时间: 2015年1月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Local Steroid Therapy within 3 momths 2. Previous history of anti-VEGF treatments 3. Past history of photodynamic therapy 4. Severe cataract 5. Local or systemic infection 6. Hisrory of uveitis 7. Apahakic eyes 8. Uncontrolled hypertension 9. Cerebrovascular or cardiac vascular accident within 6 months 10. Renal failure requiring dyalisis 11. Allegy for fluorescsin and indocyaningreen dye 12. Pregnancy or lactating 13. Other conditions that the principal investigator points out
研究者
相似试验
已完成
不适用
Investigation of clinical efficacy for Aflibercept in patients with polypoidal choroidal vasculopathy (PCV)Polypoidal Choroidal VasculopathyJPRN-UMIN000011091Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University50
招募中
4 期
Prospective study evaluating aflibercept in patients with recurrent or prolonged diabetic macular edema after vitrectomyDiabetic macular edemaJPRN-UMIN000016036Kyushu university30
已完成
不适用
Investigation of clinical efficacy of aflicbercept in patients with polypoidal choroidal vasculopathy (PCV) with resistance of ranibizumabPolypoidal choroidal vasculopathyJPRN-UMIN000012493Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo30
进行中（未招募）
1 期
Aflibercept Efficacy in Patients Suffering Age-Related Damage of the Yellow Spot of the Light-sensitive Tissue Layer in the EyeEUCTR2014-002168-34-CZDoc. MUDr. Petr Kolár, PhD, Ocní klinika FN Brno45
进行中（未招募）
1 期
AUSCorEUCTR2014-002003-25-GBBarts Health NHS Trust54